Skip to main content
. 2018 Oct 31;5(12):ofy283. doi: 10.1093/ofid/ofy283

Figure 2.

Figure 2.

A, AIDS Drug Assistance Program (ADAP)–funded Qualified Health Plan (QHP) enrollment of Cohort A by year: Cohort A was defined in a similar way from year to year (see the “Methods” or Figure 1), but the size of Cohort A increased from year 1 (2014) to year 2 (2015). For year 1 of the Virginia ADAP’s incorporation of the Affordable Care Act (ACA) into their health care delivery model, 47.1% of a similar Virginia Cohort A were enrolled in ADAP-funded QHPs [14]. This percentage increased to 63% of Cohort A for year 2. B, Viral suppression for Cohort B (clients engaged in care) with direct ADAP or ADAP-funded QHP by year: Cohort B was defined in a similar way from year to year (see the “Methods” or Figure 1). For year 1 of the Virginia ADAP’s incorporation of the ACA into their health care delivery model, 78.6% of clients in a similar Virginia Cohort B achieved 2014 viral suppression compared with 84.6% of those clients who had 2014 ADAP-funded QHP coverage [14]. For year 2, 79.9% of clients in Cohort B achieved 2015 viral suppression compared with 83.3% of those clients who had 2015 ADAP-funded QHP coverage.